Glaukos (GKOS) Total Debt (2014 - 2021)
Glaukos (GKOS) reported Total Debt of $279.3 million for Q2 2021, little changed on a QoQ basis from $279.0 million in Q1 2021.
Glaukos (GKOS) has 5 years of Total Debt data on file, last reported at $279.3 million in Q2 2021.
- Quarterly Total Debt changed N/A year-over-year to $279.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $279.3 million (changed N/A YoY) and the FY2020 annual result came in at $89.2 million, changed N/A from the prior year.
- Total Debt steadied at $279.3 million in Q2 2021 per GKOS's latest filing, from $279.0 million in the prior quarter.
- Across five years, Total Debt topped out at $279.3 million in Q2 2021 and bottomed at $89.2 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.93 Bn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 279.34 Mn |
| Mar 31, 2021 | 279.00 Mn |
| Dec 31, 2020 | 89.20 Mn |
| Sep 30, 2016 | 3.04 Mn |
| Jun 30, 2016 | 5.29 Mn |
| Mar 31, 2016 | 7.50 Mn |
| Dec 31, 2015 | 9.70 Mn |
| Sep 30, 2015 | 11.86 Mn |
| Jun 30, 2015 | 20.93 Mn |
| Dec 31, 2014 | 17.50 Mn |